J. L. Shaffer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
J. L. Shaffer has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
A. Teubner
Intestinal Failure Unit, Hope Hospital, Salford, UK
1 shared publication- Ann Micklewright
University Hospital, Queen's Medical Centre, Nottingham, UK
1 shared publication - Federico Bozzetti
Faculty of Medicine, University of Milan, Italy
1 shared publication - José Manuel Moreno-Villares
Unidad de Nutrición Clínica, Hospital Universitario 12 de Octubre, Madrid, España
1 shared publication - Kent Valentin Haderslev
Department of Gastroenterology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
1 shared publication - Loris Pironi
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
1 shared publication
Latest Publications
- Open Access
- 4 July 2007
- Published by Springer Nature in Dynamic Medicine
- Vol. 6 (1) , 7
Management of intestinal failure in Europe. A questionnaire based study on the incidence and management
Intestinal failure is the outcome of a number of gastrointestinal diseases and characterized by significant reduction in functional gut mass. If not resolved patients often face long-term nutritional support. This study gathered information about how patients referred with intestinal failure are managed in specialised European centres.
- 4 July 2007
- Published by Springer Nature in Dynamic Medicine
- Vol. 6 (1) , 7
Open AccessManagement of intestinal failure in Europe. A questionnaire based study on the incidence and management
Intestinal failure is the outcome of a number of gastrointestinal diseases and characterized by significant reduction in functional gut mass. If not resolved patients often face long-term nutritional support. This study gathered information about how patients referred with intestinal failure are managed in specialised European centres.
- 16 June 2006
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 24 (1) , 19-31
Review article: intestinal failure
Summary: Intestinal failure is a specific disease entity resulting from intestinal resection or disease‐associated malabsorption and characterized by the inability to maintain protein‐energy, fluid, electrolyte or micronutrient balance. We performed a MEDLINE search (1966–2006) to identify relevant articles, using keywords intestinal failure, parenteral or enteral nutrition, intestinal fistula and short bowel syndrome.Causes of intestinal failure are varied, with self‐limiting or ‘Type 1’ intestinal failure occurring relatively commonly following abdominal surgery, necessitating short‐term fluid or nutritional support. The rarer, ‘Type 2’ intestinal failure, is associated with septic, metabolic and complex nutritional complications, usually following surgical resection in patients with Crohn's or mesenteric vascular disease. A multidisciplinary approach to the management of patients with Type 2 intestinal failure is crucial: resolution of sepsis is required before adequate nutritional repletion can be achieved, and it is important to optimize nutritional status, not only through enteral or parenteral supplementation, but also by addressing complications of short bowel syndrome, before considering definitive surgical reconstruction.A structured approach to the management of Type 2 intestinal failure should reduce the likelihood of these complex patients developing ‘Type 3’ intestinal failure, which is characterized by the need for long‐term parenteral nutrition.
- 16 June 2006
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 24 (1) , 19-31
Review article: intestinal failure
Summary: Intestinal failure is a specific disease entity resulting from intestinal resection or disease‐associated malabsorption and characterized by the inability to maintain protein‐energy, fluid, electrolyte or micronutrient balance. We performed a MEDLINE search (1966–2006) to identify relevant articles, using keywords intestinal failure, parenteral or enteral nutrition, intestinal fistula and short bowel syndrome.Causes of intestinal failure are varied, with self‐limiting or ‘Type 1’ intestinal failure occurring relatively commonly following abdominal surgery, necessitating short‐term fluid or nutritional support. The rarer, ‘Type 2’ intestinal failure, is associated with septic, metabolic and complex nutritional complications, usually following surgical resection in patients with Crohn's or mesenteric vascular disease. A multidisciplinary approach to the management of patients with Type 2 intestinal failure is crucial: resolution of sepsis is required before adequate nutritional repletion can be achieved, and it is important to optimize nutritional status, not only through enteral or parenteral supplementation, but also by addressing complications of short bowel syndrome, before considering definitive surgical reconstruction.A structured approach to the management of Type 2 intestinal failure should reduce the likelihood of these complex patients developing ‘Type 3’ intestinal failure, which is characterized by the need for long‐term parenteral nutrition.